Clinical Trial Update: Effect of Lowering the Dialysate Sodium on Blood Pressure in Hemodialysis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effect of lowering dialysate sodium on blood pressure in patients undergoing hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Hemodialysis | Phase 3 | Status: COMPLETED